Slope is the only end-to-end, vendor-agnostic platform for managing biospecimens and clinical inventory across the entire clinical research ecosystem. Trusted by 2,200+ sites in 23+ countries, Slope ...
Oncocyte progresses towards FDA authorization for its transplant rejection monitoring test, with top U.S. centers participating in the trial. Oncocyte Corp. has made significant progress in preparing ...
RALEIGH, N.C., Aug. 26, 2025 /PRNewswire/ -- Arctx Medical, Inc. ("Arctx", "the Company"), a clinical-stage medical device company, announced today that it has achieved three significant milestones: ...
JOHNSON CITY, Tenn., Aug. 7, 2025 /PRNewswire/ -- As part of our ongoing commitment to environmental stewardship and industry leadership in sustainable clinical research, LabConnect is proud to ...
Cytespace Africa Laboratories (Cytespace), an MLM Medical Labs company and the only fully CAP-accredited central laboratory in South Africa, has significantly expanded its molecular testing ...
NEWARK, Del.--(BUSINESS WIRE)--QPS, a leading global contract research organization (CRO), is pleased to announce new laboratory services capabilities. The central laboratory, leukopak cell therapy ...
“This added capacity, a key component of our global growth and expansion strategy, supports our customers’ needs for faster, more convenient clinical trial testing and delivery across EMEA,” said ...
Hoth continues to advance HT-001 in its Phase 2 CLEER-001 clinical trial targeting EGFR-inhibitor–associated rash, a significant unmet need in oncology supportive care. Recent progress includes: ...
QPS Holdings, a global CRO, has added new features to its operations in Springfield, Missouri, that include new lab space, a pharmacy and dedicated areas to build and ship clinical trial kits. The ...
NEW YORK, Dec. 3, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (HOTH), a patient-focused clinical-stage biopharmaceutical company, today issued a comprehensive update on its therapeutic pipeline. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results